Mogamulizumab, a defucosylated anti- CCR4 humanized monoclonal antibody, in ATL, PTCL and CTCL
New Drugs in Hematology Mogamulizumab, a defucosylated anti- CCR4 humanized monoclonal antibody, in ATL, PTCL and CTCL Michinori Ogura, MD, PhD Department of Hematology/Oncology Kasugai Municipal Hospital, Japan Bologna, Royal Hotel Carlton
687 views • 26 slides